JDD Webinars

Differentiating Approach to Acne Therapy: Women Vs. Men

By October 14, 2020April 22nd, 2021No Comments

Featured Article

Differentiating Approach to Acne Therapy: Women vs. Men

Join Drs. Leon H. Kircik, MD and Julie Harper, MD as they discuss Acne severity and grade (comedonal, papulopustular, mixed, nodular), skin type, presence of acne scarring and postinflammatory hyperpigmentation, menstrual cycle history (in women), and more, as well as the factors influencing treatment with classes of topical agents.

Acne vulgaris is a chronic inflammatory dermatologic disease affecting an estimated 80% of the population at some point in their life; 85% of adolescents and young adult s may experience acne and prevalent in adults with more adult women being afflicted than adult men, raising the possibility that gender difference in skin may influence the pathogenesis of acne and treatment response.
Dermatologists indicate late-onset or adult -onset acne is becoming increasingly common in women in their 20s to 50s and research shows a large number of women over age 25 have acne and the prevalence of acne remains constant until age 44 at which time there is a decrease in incidence.

FACULTY


Leon H. Kircik, MD
Clinical Professor of Dermatology
Indiana University School of Medicine
Mount Sinai Medical Center, New York, NY
Physicians Skin Care, PLLC
Louisville, KY


Julie C. Harper, MD
Clinical Associate Professor of Dermatology
University of Alabama-Birmingham
Birmingham, Alabama

Watch Now

You May Also Like

Impact of Intermittent Fasting, Keto Diet vs Continuous Caloric Restriction on Psoriasis Severity: A Systematic Review and Meta-Analysis Protocol

| Featured Articles, Latest News, Psoriasis | No Comments
Evaluating Dietary Strategies as Adjunctive Interventions in Inflammatory Skin Disease As patients increasingly seek non-pharmacologic interventions to support their psoriasis treatment, interest in dietary modifications has surged. However, clinical guidance…
Journal of Drugs in Dermatology JDD featuring The State of Sunscreens in the US: Caveat Emptor

The State of Sunscreens in the US: Caveat Emptor

| Featured Articles, Latest News, Photoprotection | No Comments
From JDD's Vault: The State of Sunscreens in the US: Caveat Emptor  With the FDA’s groundbreaking June 2026 approval of a new sunscreen ingredient, bemotrizinol (also called BEMT or Tinosorb…
Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Beyond the Skin: Navigating Psoriasis Treatment and Patient Burden.

JDD Re:View With Dr. Beer

| Featured Articles, Latest News, Medical Derm, Psoriasis | No Comments
Beyond the Skin: Navigating Psoriasis Treatment and Patient Burden Management of psoriasis can often involve trialing several medications, extensive patient counseling, and working with insurance companies to get the optimal…

Leave a Reply